Mitsui Chemicals and Development Bank of Japan agree to acquire JSR for ¥1.84 trillion
Mitsui Chemicals and the Development Bank of Japan agreed to acquire all common shares of JSR Corporation for ¥1.84 trillion, making JSR a consolidated subsidiary of Mitsui Chemicals. The transaction remains subject to regulatory approvals and is targeted for completion in the second half of fiscal 2027.
Reuters explicitly reported on November 9, 2026 that Mitsui Chemicals would acquire JSR with the Development Bank of Japan for ¥1.84 trillion. Additional context states that Mitsui agreed to acquire all common shares, making JSR a consolidated subsidiary, with completion targeted for the second half of fiscal 2027 subject to regulatory approvals. This is a new, highly material and forward-looking control transaction, warranting the merger_acquisition type and a high importance score. Surprise is meaningful but not extreme because Mitsui’s interest had been reported several days earlier, although no decision had previously been made. The transaction is announced rather than completed, and the timestamp is tied to the filing report rather than a separately stated execution time, so timestamp confidence is below 1. Financing details are ancillary to the acquisition and are not bundled as a separate development here. The development is not a duplicate and correctly matches existing event 11583 as the confirmed milestone in the same Mitsui-JSR acquisition storyline. Only Mitsui Chemicals, JSR, and Resonac are approved as stakeholders: the first two are direct transaction parties, while Resonac had reportedly studied a possible JSR acquisition and therefore loses a documented strategic opportunity; other competitor and customer effects remain too indirect or speculative. DBJ has no exact stakeholder symbol in the supplied input.
MITSUI CHEMICAL TO ACQUIRE JSR CORP WITH DBJ, FILING SHOWS
MITSUI CHEMICAL, DBJ TO PAY 1.84 TRILLION YEN TO ACQUIRE JSR, FILING SHOWS